Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 645Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Androgel

02 2Axiron

03 6Testopel

04 3Tostran/Fortesta

05 2Voltaren

PharmaCompass

07

Brand Name : Testopel

Testosterone

arrow
CPhI Korea
Not Confirmed

Brand Name : Testopel

arrow
CPhI Korea
Not Confirmed

Testosterone

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2020 Revenue in Millions : 35

2019 Revenue in Millions : 55

Growth (%) : -36

blank

08

Brand Name : Testopel

Testosterone

arrow
CPhI Korea
Not Confirmed

Brand Name : Testopel

arrow
CPhI Korea
Not Confirmed

Testosterone

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2021 Revenue in Millions : 44

2020 Revenue in Millions : 35

Growth (%) : 24

blank

09

Brand Name : Testopel

Testosterone

arrow
CPhI Korea
Not Confirmed

Brand Name : Testopel

arrow
CPhI Korea
Not Confirmed

Testosterone

Main Therapeutic Indication : Endocrinology

Currency : USD

2022 Revenue in Millions : 39

2021 Revenue in Millions : 44

Growth (%) : -11

blank

10

Brand Name : Testopel

Testosterone

arrow
CPhI Korea
Not Confirmed

Brand Name : Testopel

arrow
CPhI Korea
Not Confirmed

Testosterone

Main Therapeutic Indication : Endocrinology

Currency : USD

2023 Revenue in Millions : 42

2022 Revenue in Millions : 39

Growth (%) : 10

blank